Detected ·
TIBEAY BioSciences
——
Dutch biotechnology startup TIBEAY BioSciences raised €35M to support a European multicenter Phase 3b trial for Ronopterin, a treatment for traumatic brain injury (TBI). The round was led by ATHOS KG with participation from MIG Capital, Meneldor, and OostNL.
- Website
- tibeay-biosciences.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-15 09:04:01 UTC
- Signal ID
- ab3024cd-1ce9-47c8-9cdf-7bee62b18715
As the API returns it
{
"id": "ab3024cd-1ce9-47c8-9cdf-7bee62b18715",
"created_at": "2026-04-15T09:04:01.130283Z",
"company_name": "TIBEAY BioSciences",
"company_website_url": "tibeay-biosciences.com",
"company_linkedin_url": "https://www.linkedin.com/company/tibeay-biosciences-b-v",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Dutch biotechnology startup TIBEAY BioSciences raised €35M to support a European multicenter Phase 3b trial for Ronopterin, a treatment for traumatic brain injury (TBI). The round was led by ATHOS KG with participation from MIG Capital, Meneldor, and OostNL.*"
}